Regarding HIF2α, a study suggested that HIF2α primarily acts on glioma stem cells, promoting stemness, sphere-forming ability, and inhibiting apoptosis, thereby worsening tumor malignancy, a finding corroborated by in vivo experiments (Li et al., 2009). This evidence concerns the gene EPAS1 and central nervous system cancer.